Feedback / Questions
GB1211 - Galecto
https://www.globenewswire.com/news-release/2024/05/01/2873595/0/en/Galecto-Announces-First-Patient-Dosed-in-an-Investigator-Initiated-Phase-2-Trial-of-GB1211-in-Combination-with-Pembrolizumab.html
May 1, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next